IRIS
RIBOLSI, MENTORE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.478
NA - Nord America 1.514
EU - Europa 740
SA - Sud America 429
AF - Africa 61
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.235
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 3.225
US - Stati Uniti d'America 1.414
CN - Cina 579
IT - Italia 343
BR - Brasile 311
HK - Hong Kong 259
VN - Vietnam 236
GB - Regno Unito 104
FR - Francia 102
DE - Germania 66
AR - Argentina 47
IN - India 45
MX - Messico 45
CA - Canada 40
ID - Indonesia 22
NL - Olanda 22
ZA - Sudafrica 22
EC - Ecuador 21
BD - Bangladesh 18
PE - Perù 15
FI - Finlandia 14
CO - Colombia 13
ES - Italia 13
PK - Pakistan 13
UA - Ucraina 11
AU - Australia 10
JP - Giappone 10
PL - Polonia 10
VE - Venezuela 9
AT - Austria 8
CZ - Repubblica Ceca 8
RU - Federazione Russa 8
EG - Egitto 7
PY - Paraguay 7
TR - Turchia 7
ET - Etiopia 6
IQ - Iraq 6
KZ - Kazakistan 6
MA - Marocco 6
UZ - Uzbekistan 6
EE - Estonia 5
IR - Iran 5
PH - Filippine 5
MY - Malesia 4
RO - Romania 4
SE - Svezia 4
TH - Thailandia 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CL - Cile 3
DO - Repubblica Dominicana 3
OM - Oman 3
PT - Portogallo 3
SA - Arabia Saudita 3
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
GA - Gabon 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
ML - Mali 2
NP - Nepal 2
TW - Taiwan 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
ME - Montenegro 1
MG - Madagascar 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NR - Nauru 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
Totale 7.229
Salva come PNG Salva come JPEG
Città #
San Jose 535
Singapore 414
Ashburn 324
Hong Kong 251
Rome 251
Hefei 171
Beijing 166
Ho Chi Minh City 96
Lauterbourg 88
Boardman 82
London 82
Dallas 69
Shanghai 51
Hanoi 49
Santa Clara 41
Council Bluffs 33
Los Angeles 32
Munich 29
Mexico City 28
São Paulo 26
Burlington 18
New York 18
Pune 13
San Francisco 13
Seattle 13
Brooklyn 12
Haiphong 12
Amsterdam 11
Frankfurt am Main 10
Johannesburg 10
West Jordan 10
Chennai 9
Chicago 9
Turku 9
Warsaw 9
Washington 9
Buffalo 8
Curitiba 8
Da Nang 8
Denver 8
Guarulhos 8
Milan 8
Quito 8
Rio de Janeiro 8
Secaucus 8
Biên Hòa 7
Guayaquil 7
Lima 7
Thái Bình 7
Toronto 7
Campinas 6
Guangzhou 6
Orem 6
Bologna 5
Dhaka 5
Helsinki 5
Medellín 5
Ninh Bình 5
Paris 5
Ribeirão Preto 5
Tokyo 5
Addis Ababa 4
Atlanta 4
Belo Horizonte 4
Bogotá 4
Brno 4
Catania 4
Chengdu 4
Hangzhou 4
Manchester 4
Palermo 4
Phoenix 4
San Juan 4
Sona 4
Stockholm 4
Tashkent 4
Thái Nguyên 4
Vienna 4
Vĩnh Tường 4
Alvorada 3
Asunción 3
Bangkok 3
Barra Bonita 3
Bauru 3
Boydton 3
Brasília 3
Córdoba 3
Guiyang 3
Hamburg 3
Jundiaí 3
Karachi 3
Lấp Vò 3
Madrid 3
Manaus 3
Melbourne 3
Montreal 3
Muscat 3
Novo Hamburgo 3
Nuremberg 3
Olomouc 3
Totale 3.303
Salva come PNG Salva come JPEG
Nome #
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 238
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 234
Applying Lyon Consensus criteria in the work‐up of patients with proton pump inhibitory‐refractory heartburn 227
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 224
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 222
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 209
Clinical impact of proton pump inhibitor response and dependence 208
Effect of the gatekeeper reflux repair system on intra-esophageal distribution of acid reflux in gastroesophageal reflux disease patients: Relation with typical symptoms 207
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 194
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 144
Achalasia, from diagnosis to treatment 140
Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD 137
Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms 136
Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters 134
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 134
Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia 130
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 127
Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review 125
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 114
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease 113
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 110
Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting 101
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 96
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 88
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 84
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 82
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 82
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 81
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 67
Psychological distress in inflammatory bowel disease 67
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 66
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 65
Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics 64
Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD 64
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 62
Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy 59
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 58
Esophageal motility disorders among elderly patients: An international multicenter study 56
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 56
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 55
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 54
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 53
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 52
The Lyon Consensus: Does It Differ From the Previous Ones? 51
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 51
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 51
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 50
Baseline impedance levels and structural and functional integrity of the esophageal mucosa: is acid still the only player? 50
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 48
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 48
Dilated intercellular space diameter as marker of reflux-related mucosal injury in children with chronic cough and gastro-oesophageal reflux disease 47
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation 45
Letter to the Editor: Relevance of a Correct GERD Patient Classification Before Anti-reflux Procedures 45
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 45
New classifications of gastroesophageal reflux disease: an improvement for patient management? 45
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world 45
Exploring the Complex Interplay Between Ineffective Esophageal Motility and Reflux Burden 44
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 44
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 44
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future 43
Nutritional aspects in inflammatory bowel diseases 43
Relevance of Excessive Air Swallowing in GERD Patients With Concomitant Functional Dyspepsia and Poor Response to PPI Therapy 42
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis 42
High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy 42
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 42
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 42
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 41
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 41
Role of Overweight and Obesity in Gastrointestinal Disease 41
Postreflux swallow-induced peristaltic wave index from pH-impedance monitoring associates with esophageal body motility and esophageal acid burden 41
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 41
Reflux characteristics triggering post-reflux swallow-induced peristaltic wave (PSPW) in patients with GERD symptoms 40
Editorial: inconclusive diagnosis of GERD: are new parameters in impedance‐pHmetry ready for clinical use? Authors' reply 40
Relationship between baseline impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease 40
PATIENTS WITH EXTRA-ESOPHAGEAL SYMPTOMS, COMPARED TO NERD PATIENTS WITH TYPICAL SYMPTOMS AND HEALTHY VOLUNTEERS, ARE CHARACTERIZED BY A HIGHER NUMBER OF REFLUX EPISODES AND HIGHER PROPORTION OF WEAKLY ACIDIC AND MIXED REFLUX 40
Exploring the association between esophageal mucosal inflammation, impaired motility, and GERD severity 39
Proximal esophageal impedance baseline increases the yield of impedance-pH monitoring for GERD diagnosis and is associated with heartburn response to PPI 39
Practice guidelines on the use of esophageal manometry – A GISMAD-SIGE-AIGO medical position statement 39
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease 39
Proximal esophageal impedance baseline increases the yield of impedance‐pH and is associated with response to PPIs in chronic cough patients 39
Nonachalasic esophageal motor disorders, from diagnosis to therapy 37
Letter: the potential link between oesophageal hypervigilance, visceral anxiety, increased swallow rate and oesophageal mucosal integrity 37
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 37
Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus 37
Editorial: Lyon consensus metrics—towards personalised diagnosis of non‐erosive reflux disease: Authors' reply 36
Towards a better diagnosis of gastro esophageal reflux disease 36
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms 36
Intercellular space diameters of the oesophageal epithelium in NERD patients: head to head comparision between light and electron microscopy 36
Letter: is wireless oesophageal pH monitoring the best technique to evaluate night‐time reflux? 35
Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease 35
Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease 35
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence 34
Should we have to include transcutaneous neuromodulation in the therapeutic GERD armamentarium? 33
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up 33
Understanding the relationship between esophageal motor disorders and reflux disease 32
Oesophageal mucosal intercellular space diameter and reflux pattern in childhood erosive and non-erosive reflux disease 30
Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallows 30
Measurement of acid exposure of proximal esophagus: a better tool for diagnosing non-erosive reflux disease 29
Short duration of acid exposure sensitizes the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease (NERD) patients 28
Letter: should we have to include baclofen in the GORD therapy armamentarium? 26
Totale 7.300
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 2 0 0 2 0 2 0 3 0 74
2022/202333 1 0 0 2 0 1 0 2 0 0 27 0
2023/2024331 5 35 42 23 18 137 3 27 3 17 15 6
2024/20253.468 39 24 117 26 42 75 62 16 230 208 1.127 1.502
2025/20263.385 355 199 298 586 171 162 889 205 288 232 0 0
Totale 7.300